penpil 40 (number 128)- sulphur, atropa belladonna pellet
paramesh banerji life sciences llc - sulfur (unii: 70fd1kfu70) (sulfur - unii:70fd1kfu70), atropa belladonna (unii: wqz3g9pf0h) (atropa belladonna - unii:wqz3g9pf0h) - heals painful and burning piles heals painful and burning piles
lyme nosode drops 2128- lyme nosode drops liquid
professional complementary health formulas - angelica archangelica 2x du huo 2x shujin chin 2x magnesia phosphorica 2x, 3x, 6x kali muriaticum 3x manganum metallicum 3x yucca filamentosa 3x cartilage 3x, 6x, 12x phytolacca decandra 4x, 12x, 30x hydrastis canadensis 5x rhus toxicodendron 6x causticum 6x, 12x, 30x hordeum vulgare 8x oxalicum acidum 8x, 12x arnica montana 8x, 100x, 1000x latrodectus mactans 10x lyme nosode 12x, 30x, 60x syphilinum 12x, 30x, 60x lyme infested deer ticks 12x, 30x, 60x rocky mountain spotted fever 12x, 30x, 60x babesia micr - for the temporary relief of minor aches in the muscles or joints, chills, sweats, fatigue, or nausea.* *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.
buvidal monthly buprenorphine 128 mg/0.36 ml modified release solution for injection
camurus pty ltd - buprenorphine, quantity: 128 mg - injection, solution - excipient ingredients: n-methyl-2-pyrrolidone; phosphatidyl choline; glyceryl dioleate; nitrogen - buvidal monthly is indicated for maintenance treatment of opioid dependence with prior stabilisation on buvidal weekly or sublingual buprenorphine or buprenorphine/naloxone within a framework of medical, social and psychological support.
juvesta 100 mg film coated tablets 128.5 mg
مستودع ادوية مسروجي - masrouji drug store - sitagliptin phosphate monohydrate 128.5 mg - 128.5 mg
oxygen gas
imedequip llc dba independent medical equipment - oxygen (unii: s88tt14065) (oxygen - unii:s88tt14065) - oxygen 99 l in 100 l
baclofen tablet
bryant ranch prepack - baclofen (unii: h789n3fke8) (baclofen - unii:h789n3fke8) - baclofen 20 mg - baclofen is useful for the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. patients should have reversible spasticity so that baclofen treatment will aid in restoring residual function. baclofen may also be of some value in patients with spinal cord injuries and other spinal cord diseases. baclofen is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders. the efficacy of baclofen in stroke, cerebral palsy, and parkinson's disease has not been established and, therefore, it is not recommended for these conditions. hypersensitivity to baclofen.
telmisartan and hydrochlorothiazide - telmisartan and hydrochlorothiazide tablet
macleods pharmaceuticals limited - telmisartan (unii: u5syw473rq) (telmisartan - unii:u5syw473rq), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - telmisartan 40 mg - telmisartan and hydrochlorothiazide tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the classes to which this drug principally belongs. there are no controlled trials demonstrating risk reduction with telmisartan and hydrochlorothiazide tablets. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national commit
xenon- xenon xe-133 gas
lantheus medical imaging, inc. - xenon xe-133 (unii: x3p9a5hnyf) (xenon xe-133 - unii:x3p9a5hnyf) - xenon xe-133 10 mci - inhalation of xenon xe 133 gas has proved valuable for the evaluation of pulmonary function and for imaging the lungs. it may also be applied to assessment of cerebral flow. none known.
hydroxyzine hydrochloride- hydroxyzine hydrochloride tablet, film coated
mutual pharmaceutical company, inc. - hydroxyzine hydrochloride (unii: 76755771u3) (hydroxyzine - unii:30s50ym8og) - tablet, film coated - 10 mg - for symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested. useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus. as a sedative when used as premedication and following general anesthesia, hydroxyzine may potentiate meperidine and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. atropine and other belladonna alkaloids are not affected by the drug. hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent. the effectiveness of hydroxyzine as an antianxiety agent for long term use, that is more than 4 months, has not been assessed by systematic clinical studies. the physician should reassess periodically the usefulness of the drug for the individual patient. hydroxyzine, when administered t
clonidine hydrochloride tablet
actavis pharma, inc. - clonidine hydrochloride (unii: w76i6xxf06) (clonidine - unii:mn3l5rmn02) - clonidine hydrochloride 0.1 mg - clonidine hydrochloride tablets are indicated in the treatment of hypertension. clonidine hydrochloride tablets may be employed alone or concomitantly with other antihypertensive agents. clonidine hydrochloride tablets should not be used in patients with known hypersensitivity to clonidine (see precautions ).